Davie, Alison, Sory Traoré, Massimo Giovannitti, Giuseppe Pompilio, Mark Lambton, Esra Cakar, and Anuja Chatterjee. 2023. “Cost-Effectiveness Analysis of Abemaciclib With Endocrine Therapy (ET) Versus ET Alone for HR+, HER2−, Node-Positive, High-Risk Early Breast Cancer in Italy”. Global and Regional Health Technology Assessment 10 (1):62-69. https://doi.org/10.33393/grhta.2023.2561.